Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Shanghai MicroPort MedBot (Group) Co., Ltd. Class H ( (HK:2252) ) is now available.
Shanghai MicroPort MedBot (Group) Co., Ltd. has announced an extraordinary general meeting scheduled for November 25, 2025, to discuss several key appointments to its board of directors, including both non-executive and independent non-executive roles. Additionally, the meeting will address proposed amendments to the company’s Articles of Association and the Rules of Procedure for the General Meeting of Shareholders, which could impact the company’s governance and operational procedures.
The most recent analyst rating on (HK:2252) stock is a Buy with a HK$42.00 price target. To see the full list of analyst forecasts on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H stock, see the HK:2252 Stock Forecast page.
More about Shanghai MicroPort MedBot (Group) Co., Ltd. Class H
Shanghai MicroPort MedBot (Group) Co., Ltd. operates in the medical technology industry, focusing on the development and production of robotic surgical systems. The company is based in China and is involved in the innovation and commercialization of minimally invasive surgical solutions.
Average Trading Volume: 6,722,142
Technical Sentiment Signal: Buy
Current Market Cap: HK$26.07B
For an in-depth examination of 2252 stock, go to TipRanks’ Overview page.